Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Central Nervous System Prophylaxis Is Required and Associated with a Prolonged Overall Survival in Both Early and Advanced-Stage Primary Adrenal/Renal Diffuse Large B-Cell Lymphoma

John Xie, MD, Motohide Uemura, MD PhD, Shigeaki Nakazawa, MD PhD, Teresa Calimeri, MD PhD, Andres JM Ferreri, MD, Francisco Socola, MD, Hana Safah, MD, Nakhle S. Saba, MD

Blood (2019) 134 (Supplement_1): 2908.

https://doi.org/10.1182/blood-2019-129158

Published: 2019

Journal Articles

Sequential Matrix-RICE Therapy Followed By Autologous Stem Cell Transplant in Patients with Diffuse Large B-Cell Lymphoma and Secondary Central Nervous System Involvement: The International Extranodal Lymphoma Study Group-42 Phase II (MARIETTA) Trial

Blood (2019) 134 (Supplement_1): 353.

https://doi.org/10.1182/blood-2019-129835

Published: 2019

Journal Articles

Clinical Relevance of MYD88 L265P Mutation and Interleukin-10 Level in Cerebrospinal Fluid of Patients with Both Newly Diagnosed and Relapsed Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Blood (2019) 134 (Supplement_1): 4114.

https://doi.org/10.1182/blood-2019-128298

Published: 2019

Journal Articles

Lenalidomide Maintenance Significantly Improves Survival Figures in Patients with Relapsed Diffuse Large B-Cell Lymphoma (rDLBCL) Who Are Not Eligible for Autologous Stem Cell Transplantation (ASCT): Final Results of a Multicentre Phase II Trial

Blood (2016) 128 (22): 474.

https://doi.org/10.1182/blood.V128.22.474.474

Published: 2016

Journal Articles

Apurinic/Apyrimidinic Endonuclease 1 Induced Genomic Instability Causes T-Cell Acute Lymphoblastic Leukemia in Zebrafish

Jianhong Lin, MD M.Sc, Chun Yang, MD PhD, Ariel Kwart, B.S., Jianjun Zhao, MD PhD, Mehmet K Samur, PhD, Weihong Zhang, MD, Purushothama Nanjappa, M.S., Teresa Calimeri, MD PhD, Xiubao Ren, MD, Dongdong Ma, MD PhD, Xiaofeng Jiang, MD PhD, Yi Zhou, PhD, Masood Shammas, PhD, Kenneth C. Anderson, MD, Jon C. Aster, MD PhD, Leonard I. Zon, MD, Robert I. Handin, MD, Nikhil C. Munshi, MD

Blood (2015) 126 (23): 1431.

https://doi.org/10.1182/blood.V126.23.1431.1431

Published: 2015

Journal Articles

MiR-29b Counteracts Aberrant HDAC4 Expression and Enhances Vorinostat Activity in Multiple Myeloma

Nicola Amodio, PhD, Marzia Leotta, MD, Anna Maria Gullà, MD, Lavinia Raimondi, PhD, Eugenio Morelli, MD, Maria Angelica Stamato, Teresa Calimeri, MD PhD, Maria Teresa Di Martino, PhD, Marco Rossi, MD, Emanuela Leone, PhD, Antonino Neri, Pierosandro Tagliaferri, MD, Pierfrancesco Tassone, MD

Blood (2014) 124 (21): 2060.

https://doi.org/10.1182/blood.V124.21.2060.2060

Published: 2014

Journal Articles

Selective G-Protein Estrogen Receptor (GPER) Activation Triggers Anti-Multiple Myeloma Activity and Synergizes with MiR-29b-Inducing Drugs

Nicola Amodio, PhD, Marzia Leotta, MD, Eugenio Morelli, MD, Teresa Calimeri, MD PhD, Anna Maria Gullà, MD, Maria Angelica Stamato, Enrica Romeo, Umberto Foresta, PhDstudent, Antonino Neri, Maria Teresa Di Martino, PhD, Pierosandro Tagliaferri, MD, Pierfrancesco Tassone, MD

Blood (2014) 124 (21): 4725.

https://doi.org/10.1182/blood.V124.21.4725.4725

Published: 2014

Journal Articles

Targeting Aberrant Non-Homologous End Joining in Multiple Myeloma: Role of the Classical and Alternative Pathways in Genomic Instability

Teresa Calimeri, MD PhD, Daniele Caracciolo, MD, Nicola Amodio, PhD, Mehmet Kemal Samur, PhD, Marzia Leotta, MD, Mariateresa Fulciniti, PhD, Marco Rossi, MD, Stephane Minvielle, Herve Avet-Loiseau, Pierosandro Tagliaferri, MD, Masood Shammas, PhD, Kenneth C. Anderson, Pierfrancesco Tassone, MD, Nikhil C. Munshi, MD

Blood (2014) 124 (21): 3417.

https://doi.org/10.1182/blood.V124.21.3417.3417

Published: 2014

Journal Articles

Tumor Suppressor MiR-29b Targets HDAC4 and Modulates Vorinostat Activity In Multiple Myeloma Cells

Nicola Amodio, PhD, Marzia Leotta, MD, Lavinia Biamonte, PhD, Teresa Calimeri, MD, Eugenio Morelli, MD, Umberto Foresta, PhD, Maria Teresa Di Martino, PhD, Marco Rossi, MD, Emanuela Leone, PhD, Antonino Neri, MD, Pierosandro Tagliaferri, MD, Pierfrancesco Tassone, MD

Blood (2013) 122 (21): 4451.

https://doi.org/10.1182/blood.V122.21.4451.4451

Published: 2013

Journal Articles

Mir-23b Plays a Critical Role As a Tumor Suppressor miRNA In Multiple Myeloma

Mariateresa Fulciniti, PhD, Nicola Amodio, PhD, Rajya Bandi, Rao H. Prabhala, Ph.D., Sophia Adamia, PhD, Teresa Calimeri, MD, Lavinia Biamonte, PhD, Marzia Leotta, MD, Kenneth C. Anderson, MD, Pierfrancesco Tassone, MD, Munshi C Nikhil, MD

Blood (2013) 122 (21): 122.

https://doi.org/10.1182/blood.V122.21.122.122

Published: 2013

Journal Articles

Non Homologous End Joining, a Marker Of Genomic Instability Is Elevated In Multiple Myeloma: A New Prognostic Factor

Teresa Calimeri, MD, Mehmet Kemal Samur, PhD, Nicola Amodio, PhD, Michele Cea, MD, Antonia Cagnetta, MD, Mariateresa Fulciniti, PhD, Sophia Adamia, PhD, Marco Rossi, MD, Yu-Tzu Tai, PhD, Fortunato Morabito, MD, Abdel Kareem Azab, BPharm, PhD, Stephane Minvielle, PhD, Herve Avet-Loiseau, MD, Cheng Li, PhD, Jean-Bernard Lazaro, PhD, Kenneth C. Anderson, Masood A. Shammas, Pierfrancesco Tassone, MD, Nikhil C. Munshi, MD

Blood (2013) 122 (21): 124.

https://doi.org/10.1182/blood.V122.21.124.124

Published: 2013

Journal Articles

Telomerase Contributes To Repair Of DNA Breaks In Myeloma Cells By Incorporating “TTAGGG” Sequences Within Genome: Biological and Translational Significance

Jagannath Pal, PhD, Jie Ding, PhD, Subodh Kumar, PhD, Zachary Hunter, Teresa Calimeri, MD, Jianhong Lin, Maria Gkotzamanidou, MD, Giovanni Parmigiani, PhD, Steven Treon, Masood Shammas, PhD, Nikhil Munshi, MD

Blood (2013) 122 (21): 1249.

https://doi.org/10.1182/blood.V122.21.1249.1249

Published: 2013

Journal Articles

Aberrant Non-Homologous End Joining in Multiple Myeloma: A Role in Genomic Instability and As Potential Prognostic Marker.

Blood (2012) 120 (21): 2932.

https://doi.org/10.1182/blood.V120.21.2932.2932

Published: 2012

Journal Articles

Intracellular NAD + Depletion Enhances Bortezomib-Induced Myeloma Cytotoxicity

Antonia Cagnetta, MD, Michele Cea, MD, Chirag Acharya, MD, Teresa Calimeri, MD, Yu-Tzu Tai, PhD, Teru Hideshima, MD, PhD, Dharminder Chauhan, PhD, Franco Patrone, Marco Gobbi, MD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD

Blood (2012) 120 (21): 330.

https://doi.org/10.1182/blood.V120.21.330.330

Published: 2012

Journal Articles

Modulation of Gene Expression Profile and In Vivo Anti-Myeloma Activity Induced by Valproic Acid, a Histone Deacytylase Inhibitor.

Paola Neri, MD, Teresa Calimeri, MD, Mariateresa Di Martino, PhD, Marco Rossi, MD, Orietta Eramo, PhD, Mariagrazia Propato, MD, Gino Perri, MD, Antonella Pietragalla, MD, Monica Ventura, MD, Alessandra Bulotta, MD, Simona Blotta, MD, Pierosandro Tagliaferri, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD, Pierfrancesco Tassone, MD

Blood (2007) 110 (11): 4790.

https://doi.org/10.1182/blood.V110.11.4790.4790

Published: 2007

NARROW

Central Nervous System Prophylaxis Is Required and Associated with a Prolonged Overall Survival in Both Early and Advanced-Stage Primary Adrenal/Renal Diffuse Large B-Cell Lymphoma

Sequential Matrix-RICE Therapy Followed By Autologous Stem Cell Transplant in Patients with Diffuse Large B-Cell Lymphoma and Secondary Central Nervous System Involvement: The International Extranodal Lymphoma Study Group-42 Phase II (MARIETTA) Trial

Clinical Relevance of MYD88 L265P Mutation and Interleukin-10 Level in Cerebrospinal Fluid of Patients with Both Newly Diagnosed and Relapsed Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Lenalidomide Maintenance Significantly Improves Survival Figures in Patients with Relapsed Diffuse Large B-Cell Lymphoma (rDLBCL) Who Are Not Eligible for Autologous Stem Cell Transplantation (ASCT): Final Results of a Multicentre Phase II Trial

Apurinic/Apyrimidinic Endonuclease 1 Induced Genomic Instability Causes T-Cell Acute Lymphoblastic Leukemia in Zebrafish

MiR-29b Counteracts Aberrant HDAC4 Expression and Enhances Vorinostat Activity in Multiple Myeloma

Selective G-Protein Estrogen Receptor (GPER) Activation Triggers Anti-Multiple Myeloma Activity and Synergizes with MiR-29b-Inducing Drugs

Targeting Aberrant Non-Homologous End Joining in Multiple Myeloma: Role of the Classical and Alternative Pathways in Genomic Instability

Tumor Suppressor MiR-29b Targets HDAC4 and Modulates Vorinostat Activity In Multiple Myeloma Cells

Mir-23b Plays a Critical Role As a Tumor Suppressor miRNA In Multiple Myeloma

Non Homologous End Joining, a Marker Of Genomic Instability Is Elevated In Multiple Myeloma: A New Prognostic Factor

Telomerase Contributes To Repair Of DNA Breaks In Myeloma Cells By Incorporating “TTAGGG” Sequences Within Genome: Biological and Translational Significance

Aberrant Non-Homologous End Joining in Multiple Myeloma: A Role in Genomic Instability and As Potential Prognostic Marker.

Intracellular NAD + Depletion Enhances Bortezomib-Induced Myeloma Cytotoxicity

Modulation of Gene Expression Profile and In Vivo Anti-Myeloma Activity Induced by Valproic Acid, a Histone Deacytylase Inhibitor.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only